SAFETY AND EFFICACY OF nab®-PACLITAXEL (ABRAXANE®) IN COMBINATION WITH CARBOPLATIN AS FIRST LINE TREATMENT IN ELDERLY SUBJECTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE IV, RANDOMIZED, OPEN-LABEL - Regional Cancer Care Associates LLC

Clinical Trials

SAFETY AND EFFICACY OF nab®-PACLITAXEL (ABRAXANE®) IN COMBINATION WITH CARBOPLATIN AS FIRST LINE TREATMENT IN ELDERLY SUBJECTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE IV, RANDOMIZED, OPEN-LABEL

Type of Cancer
Lung
Locations
Sparta
Sponsor
Celgene
Protocol Number
ABI 007-NSCL-005
Cancer Diagnosis
To Learn More Call
201-510-0910